174 related articles for article (PubMed ID: 16632438)
21. Intraocular retinoblastoma group V: an analysis of prognostic factors.
Rubin CM; Robison LL; Cameron JD; Woods WG; Nesbit ME; Krivit W; Kim TH; Letson RD; Ramsay NK
J Clin Oncol; 1985 May; 3(5):680-5. PubMed ID: 3998784
[TBL] [Abstract][Full Text] [Related]
22. The treatment of retinoblastoma.
Höpping W; Renelt P
Mod Probl Ophthalmol; 1974; 12(0):580-7. PubMed ID: 4424896
[No Abstract] [Full Text] [Related]
23. Outcomes of pediatric retinoblastoma treated with ICEV regimen: A single-center study.
Buaboonnam J; Narkbunnam N; Vathana N; Takpradit C; Phuakpet K; Pongtanakul B; Tongsai S; Atchaneeyasakul LO; Sanpakit K
Pediatr Hematol Oncol; 2019 Mar; 36(2):73-81. PubMed ID: 30983466
[TBL] [Abstract][Full Text] [Related]
24. Response of orbital and central nervous system metastases of retinoblastoma following treatment with cyclophosphamide/doxorubicin.
Pratt CB; Kun LE
Pediatr Hematol Oncol; 1987; 4(2):125-30. PubMed ID: 3152919
[TBL] [Abstract][Full Text] [Related]
25. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
Turaka K; Shields CL; Meadows AT; Leahey A
Pediatr Blood Cancer; 2012 Jul; 59(1):121-5. PubMed ID: 21826785
[TBL] [Abstract][Full Text] [Related]
26. Treatment outcome and dose-response relationship in infants younger than 1 year treated for retinoblastoma with primary irradiation.
Fontanesi J; Pratt CB; Kun LE; Hustu HO; Coffey D; Meyer D
Med Pediatr Oncol; 1996 May; 26(5):297-304. PubMed ID: 8614362
[TBL] [Abstract][Full Text] [Related]
27. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
Dunkel IJ; Khakoo Y; Kernan NA; Gershon T; Gilheeney S; Lyden DC; Wolden SL; Orjuela M; Gardner SL; Abramson DH
Pediatr Blood Cancer; 2010 Jul; 55(1):55-9. PubMed ID: 20486171
[TBL] [Abstract][Full Text] [Related]
28. Characterization, treatment and prognosis of retinoblastoma with central nervous system metastasis.
Hu H; Zhang W; Wang Y; Huang D; Shi J; Li B; Zhang Y; Zhou Y
BMC Ophthalmol; 2018 Apr; 18(1):107. PubMed ID: 29685116
[TBL] [Abstract][Full Text] [Related]
29. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma.
Kremens B; Wieland R; Reinhard H; Neubert D; Beck JD; Klingebiel T; Bornfeld N; Havers W
Bone Marrow Transplant; 2003 Feb; 31(4):281-4. PubMed ID: 12621463
[TBL] [Abstract][Full Text] [Related]
30. Postenucleation orbits in retinoblastoma: treatment with 125I brachytherapy.
Stannard C; Sealy R; Hering E; Hough J; Knowles R; Lecuona K; Reddi VB
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1446-54. PubMed ID: 12459368
[TBL] [Abstract][Full Text] [Related]
31. [Radiotherapy in the multimodality treatment of retinoblastomas in children].
Goldobenko GV; Durnov LA; Lobanov GV; Liutova NA; Belkina BM
Med Radiol (Mosk); 1985 Dec; 30(12):3-7. PubMed ID: 4079688
[TBL] [Abstract][Full Text] [Related]
32. Extraocular retinoblastoma: a 13-year experience.
Antoneli CB; Steinhorst F; de Cássia Braga Ribeiro K; Novaes PE; Chojniak MM; Arias V; de Camargo B
Cancer; 2003 Sep; 98(6):1292-8. PubMed ID: 12973854
[TBL] [Abstract][Full Text] [Related]
33. Precision megavoltage external beam radiation therapy for retinoblastoma.
Schipper J; Imhoff SM; Tan KE
Front Radiat Ther Oncol; 1997; 30():65-80. PubMed ID: 9205886
[No Abstract] [Full Text] [Related]
34. Preliminary results of primary chemotherapy in retinoblastoma.
Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W
Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
[TBL] [Abstract][Full Text] [Related]
35. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
[TBL] [Abstract][Full Text] [Related]
36. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center.
Ozdemir H; Tacyildiz N; Unal E; Yavuz G; Ugur H; Gunduz K
Pediatr Hematol Oncol; 2007; 24(3):221-31. PubMed ID: 17454793
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of children with retinoblastoma.
Nahum MP; Gdal-On M; Kuten A; Herzl G; Horovitz Y; Weyl Ben Arush M
Pediatr Hematol Oncol; 2001; 18(3):173-9. PubMed ID: 11293284
[TBL] [Abstract][Full Text] [Related]
38. [Prognosis and treatment of retinoblastoma. 105 cases treated at the Curie Institute].
Haye C; Desjardins L; Elmaleh C; Schlienger P; Zucker JM; Laurent M
Ophtalmologie; 1989; 3(3):183-6. PubMed ID: 2641106
[TBL] [Abstract][Full Text] [Related]
39. A prospective study on the treatment of retinoblastoma in 72 patients.
Zelter M; Damel A; Gonzalez G; Schwartz L
Cancer; 1991 Oct; 68(8):1685-90. PubMed ID: 1913508
[TBL] [Abstract][Full Text] [Related]
40. Phase II window of idarubicin in children with extraocular retinoblastoma.
Chantada GL; Fandiño A; Mato G; Casak S
J Clin Oncol; 1999 Jun; 17(6):1847-50. PubMed ID: 10561224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
